To maximize hydrogen output, specific genetic modifications are proposed for the microbial strains Clostridium butyricum and Rhodobacter sphaeroides. These edits aim to enhance hydrogenase activity, suppress competing pathways, expand substrate flexibility, and increase cofactor and ATP availability. All modifications are assumed to be integrated chromosomally via CRISPR-Cas9 or homologous recombination techniques, with stable expression under anaerobic or light-inducible promoters. Potential metabolic burden, redox imbalances, and long-term evolutionary responses are excluded from the scope of this model.
4.3. Genetic Integration Challenges and Model Assumptions
While each proposed genetic edit in isolation has been documented to improve hydrogen yield or metabolic efficiency, the assumption of full functional compatibility across a multi-gene stack presents a significant risk of overestimation. In real-world systems, combinatorial gene stacking beyond 3–4 edits frequently result in metabolic crosstalk, resource exhaustion, and unexpected feedback inhibition.
For facultative anaerobes like Clostridium butyricum and Rhodobacter sphaeroides, regulatory networks often suppress overexpression to maintain redox balance and cellular homeostasis. Literature suggests that above 4–5 simultaneous edits, constructive collaboration tends to plateau—and in some cases, becomes negative due to ribosomal bottlenecking, cofactor depletion, or transcript interference.
Therefore, while this model includes a 6–8 gene modification set for theoretical benchmarking, it is explicitly treated as a ceiling scenario. Actual implementation may require modular optimization or sequential engineering to preserve system stability. Future modelling efforts should incorporate a constructive collaboration correction factor or simulate dynamic trade-offs using flux balance or gene regulatory network models to determine yield inflection points under escalating metabolic burden.
This model assumes these modifications are functionally expressed and do not trigger regulatory shutdowns or metabolic collapse. These assumptions are made to isolate the theoretical yield ceiling of optimized microbial strains. Future iterations of the model will need to incorporate dynamic flux balance analysis (dFBA), metabolic burden modelling, or resource allocation frameworks to refine viability assessments for these engineered systems.
Similar enhancements in Clostridium spp. and Rhodobacter spp. have achieved 1.8x–3.5x increases in H₂ yield in batch systems under lab conditions [e.g., Hallenbeck et al., 2009; McKinlay & Harwood, 2010; Thaiwong et al., 2015]. This model builds upon those pathways with additional combinatorial edits. While constructive collaboration between these edits has not been empirically validated as a unified stack, this model assumes compatibility under optimized cellular conditions.
Based on literature, multi-gene overexpression systems in facultative anaerobes often experience 10–25% loss in target expression over extended growth due to mutation, regulatory repression, or resource depletion [ref Hallenbeck, McKinlay]. While the current model assumes full expression, a Biological Realism Factor (BRF) of 0.75–0.9 can be used to adjust theoretical rates in future kinetic simulations.
These genetic assumptions define the theoretical design envelope for engineered biohydrogen systems. While this paper explores the idealized ceiling, future work should define a performance corridor bounded by expected losses in expression fidelity, cofactor availability, and adaptive mutagenesis. Such a corridor would allow scenario-based system planning those accounts for both synthetic potential and biological resistance.
| Genetic Edit |
Intended Effect |
Metabolic Cost |
Stability Risk |
Impact on Yield |
| hydA↑ |
↑ H₂ production |
ATP, Fe-S cluster draw |
Moderate |
High |
| hydG∆ |
↑ Maturation |
Low |
Low |
Medium |
| bchP↑ |
↑ Light absorption |
NADPH usage |
High |
Medium |
| hupL∆ |
↓ H2 Loss |
None |
Very Low |
Medium |
| crtB↑ |
↑ Light Stability |
Membrane strain |
Medium |
Medium |
4.3.1. Stack Compatibility and Synergy Limitations
While each proposed genetic edit in isolation has been documented to improve hydrogen yield or metabolic efficiency, the assumption of full functional compatibility across a multi-gene stack presents a significant risk of overestimation. In real-world systems, combinatorial gene stacking beyond 3–4 edits frequently result in metabolic crosstalk, resource exhaustion, and unexpected feedback inhibition.
For facultative anaerobes like Clostridium butyricum and Rhodobacter sphaeroides, regulatory networks often suppress overexpression to maintain redox balance and cellular homeostasis. Literature suggests that above 4–5 simultaneous edits, constructive collaboration tends to plateau—and in some cases, becomes negative due to ribosomal bottlenecking, cofactor depletion, or transcript interference.
Therefore, while this model includes a 6–8 gene modification set for theoretical benchmarking, it is explicitly treated as a ceiling scenario. Actual implementation may require modular optimization or sequential engineering to preserve system stability. Future modelling efforts should incorporate a constructive collaboration correction factor or simulate dynamic trade-offs using flux balance or gene regulatory network models to determine yield inflection points under escalating metabolic burden.
4.4. Gene Stack Resource Load and Metabolic Burden Quantification
While the previous sections described genetic modifications in Clostridium butyricum and Rhodobacter sphaeroides to enhance hydrogen production, this subsection addresses the metabolic and biochemical resource requirements imposed by these edits. Quantifying these demands is essential to assess whether the engineered strains could sustain high-yield hydrogen production without exceeding physiological tolerances or collapsing under resource depletion.
| Genes Added |
Expected Yield Boost (%) |
Stability Risk |
| 1–2 |
+20–40% |
Low |
| 3–4 |
+40–70% |
Medium |
| 5–6 |
+70–90% |
High |
| 7+ |
Marginal or Negative |
Very High |
While this model assumes that overexpression of hydrogenases and associated enzymes leads to enhanced hydrogen yield, it is important to note that enzyme activity does not scale linearly with gene expression levels. In practice, increasing transcription may not proportionally increase catalytic turnover due to substrate limitation, cofactor saturation, and feedback regulation. For example, hydrogenase activity may plateau at high expression levels if reduced ferredoxin or NAD(P)H becomes limiting. Additionally, overexpression may lead to improper protein folding or inclusion body formation, particularly under metabolic stress. Therefore, the relationship between gene dosage and hydrogen yield is subject to diminishing returns beyond certain thresholds, and this model's assumptions should be interpreted as reflecting best-case catalytic availability rather than guaranteed performance scaling.
While this model assumes stable expression of a 6–8 gene enhancement set, real-world systems often exhibit diminished returns beyond 4 simultaneous edits due to transcriptional overload, ribosomal crowding, and cofactor scarcity. To bridge the gap between theoretical performance and practical expression limits, we introduce a Gene Stack Correction Factor (GSCF) as a heuristic yield modifier. This factor reflects the non-linear yield penalties associated with stacked edits and can be applied multiplicatively to the uncorrected hydrogen yield. Based on published microbial engineering studies, a GSCF of 0.6–0.9 is proposed depending on stack complexity and metabolic burden. For example, if the system theoretically produces 12 mol H₂ per cycle, a GSCF of 0.75 would reduce the adjusted yield to 9 mol—a more biologically plausible outcome under high-expression load. This correction aligns the model with empirical observations while preserving its utility as a theoretical ceiling. All future system designs should benchmark gene stack size against yield plateau thresholds to avoid metabolic collapse or regulatory interference.
4.4.1. ATP Demand from Nitrogenase Activity
The photofermentation stage, driven by R. sphaeroides, relies on nitrogenase to catalyse hydrogen evolution from water and VFAs. Nitrogenase is ATP-intensive, requiring approximately 16–24 ATP per mole of H₂ produced. This model adopts a midpoint estimate of 20 ATP/mol H₂, resulting in a total demand of 200 ATP per mole of glucose processed (given 10 mol H₂ from photofermentation).
While some of this ATP is regenerated via acetate metabolism (enhanced by ackA insertion) and cyclic photophosphorylation, sustained operation requires a robust intracellular ATP supply and efficient cofactor cycling.
4.4.1.1. ATP Demand vs. ATP Supply — Balancing Constraints
Nitrogenase-driven hydrogen evolution imposes a heavy ATP cost—estimated here at 20 ATP per mole of H₂, resulting in a demand of 200 mol ATP per cycle to produce 10 mol H₂ in the photofermentative stage. While the model assumes that ATP is regenerated via acetate metabolism (enhanced through ackA insertion) and cyclic photophosphorylation, this assumption represents a best-case energy budget that is rarely achievable without active metabolic steering.
Acetate metabolism contributes an estimated 1–2 ATP per mol acetate, and photophosphorylation offers 2–4 ATP per mol H₂ at optimal photon flux. However, real-world systems often experience suboptimal light exposure, cofactor scarcity, or carbon flux diversion—resulting in partial ATP regeneration. A conservative integration of these yields suggests a probable output of only 100–150 mol ATP per cycle, leaving a shortfall of 25–50%.
This ATP deficit would likely throttle nitrogenase activity, delaying or capping photofermentative hydrogen yield. If ATP availability drops below critical thresholds, not only does H₂ evolution slow, but redox balancing and cofactor recycling are also disrupted—introducing systemic instability and potential feedback inhibition.
A corrected model scenario assuming only 150 mol ATP available would reduce photofermentative H₂ production proportionally—from 10 mol down to ~7.5 mol, decreasing the total cycle yield from 12 mol to ~9.5 mol.
Future iterations of this model should integrate dynamic ATP flux simulations, using flux balance analysis (FBA) or constraint-based modelling to quantify enzyme activity throttling under resource-limited conditions. Until then, this section presents an upper-bound yield scenario, with clearly defined ATP bottlenecks as a realism modifier.
Clarification on Cyclic Photophosphorylation ATP Output:
The estimated ATP output from cyclic photophosphorylation (2–4 mol ATP per mol H₂) is based on indirect analogues from purple non-sulphur bacteria and phototrophic growth models under nitrogen-limited conditions. Empirical studies, such as those by Gest and Kamen (1993) and Madigan et al. (2010), suggest that cyclic electron flow through the photosynthetic apparatus in Rhodobacter sphaeroides can regenerate ATP at rates sufficient to support nitrogenase activity when paired with acetate metabolism. While exact stoichiometries vary due to differences in proton motive force efficiency and ATP synthase coupling ratios, ATP yields in this range have been inferred from nitrogen-fixation-associated photophosphorylation experiments. Therefore, the model adopts this bracketed estimate as a biologically plausible range under ideal light intensity and uninterrupted electron flow conditions. Further refinement would require kinetic simulations of electron transport rates and intracellular ATP flux.
References available on request or in supplementary materials.
A conservative ATP accounting is as follows:
| Source |
Estimated ATP Yield |
Comments |
| Acetate pathway (ackA/pta) |
~1–2 mol ATP per mol acetate |
Limited by carbon flux and available acetate; assumes full routing from glucose |
| Cyclic photophosphorylation |
Variable (2–4 ATP/mol H₂ at best) |
Highly dependent on light intensity and electron transport efficiency |
| Total Expected ATP |
~100–150 mol (upper-bound) |
Potentially insufficient under realistic light or metabolic conditions |
| Required ATP |
200 mol |
For 10 mol H₂ at 20 ATP/mol H₂ |
Gap: Up to 50–100 mol ATP shortfall may occur if substrate-level phosphorylation or light-driven ATP regeneration is suboptimal.
Implication: Without precise control of metabolic routing and light efficiency, nitrogenase activity may be throttled due to intracellular ATP scarcity. This would reduce hydrogen yield and/or trigger stress responses that disrupt expression stability.
A full ATP budget under dynamic conditions should be incorporated into future models using flux balance analysis (FBA) or kinetic simulations. For now, the system’s ATP sufficiency is treated as a limiting factor, and actual hydrogen yields may fall below the theoretical ceiling unless additional ATP-regenerating strategies are employed (e.g., enhanced cyclic electron flow, acetate supplementation, or heterologous ATP synthase integration).
Realistic ATP-Limited Yield Adjustment
Based on current pathway estimates, the photofermentation stage demands ~200 mol ATP per cycle to drive nitrogenase-catalysed hydrogen evolution. However, the model's ATP supply—via acetate metabolism and cyclic photophosphorylation—realistically maxes out between 100–150 mol ATP per cycle under optimal conditions. This leaves a projected ATP deficit of 25–50%, which proportionally throttles nitrogenase activity. Assuming a linear ATP-to-H₂ coupling (20 ATP/mol H₂), this implies a revised photofermentative hydrogen yield of 7.5–9 mol H₂, depending on metabolic routing and light conditions.
Accordingly, the system’s total hydrogen yield per cycle drops from 12 mol to ~9.5–11 mol, once ATP availability is considered. Future models should integrate ATP-coupled flux penalties directly into kinetic simulations to capture this constraint more dynamically. Until then, the current model's full-yield scenario should be interpreted as a theoretical ceiling contingent on ideal energy regeneration, uninterrupted light flux, and acetate availability. Any deviation from these assumptions risks substantial yield collapse due to ATP bottlenecks.
4.4.2. Fe-S Cluster and Metal Cofactor Requirements
Both [FeFe]-hydrogenase (overexpressed via hydA↑) and nitrogenase require
iron-sulphur (Fe-S) clusters, with nitrogenase additionally requiring molybdenum. The biosynthesis of these cofactors is ATP-dependent and sensitive to intracellular metal availability.
| Enzyme |
Fe Requirement |
Key Cofactor |
| [Fe-Fe]-hydrogenase |
2-3 Fe atoms per unit |
Fe-S clusters |
| Nitrogenase (NifDK) |
~8 Fe, 7 S, 1 Mo |
Fe-S MoFe cofactor |
Without sufficient Fe²⁺ and MoO₄²⁻ supplementation, expression levels will bottleneck. Real-world microbial cultures often experience yield collapse when metal availability becomes rate-limiting, particularly in continuous systems.
4.4.2.1. Cofactor Limitations as a Performance Bottleneck
The model assumes sufficient supplementation of trace metals such as Fe²⁺ and MoO₄²⁻ to support the biosynthesis of Fe-S clusters and the FeMo cofactor required for [FeFe]-hydrogenase and nitrogenase, respectively. However, this oversimplifies the bioavailability kinetics and competitive uptake dynamics that occur in microbial cultures.
In continuous bioreactors or batch systems with high expression burdens, trace metals often become rate-limiting not due to absolute absence—but due to poor solubility, ion competition, or metabolic uptake saturation. For instance, Fe²⁺ must compete with Mn²⁺, Zn²⁺, and Cu²⁺ at membrane transporters, while molybdate (MoO₄²⁻) can be competitively inhibited by sulphate or phosphate anions.
Additionally, Fe-S cluster assembly is an ATP-dependent, protein-mediated process requiring coordination with HydE/F/G maturation pathways. Any disruption—whether from cofactor scarcity, oxidative stress, or pH drift—can stall hydrogenase/nitrogenase assembly and sharply reduce yield.
This model does not yet simulate:
Transporter affinity thresholds for metal uptake
Chelation kinetics in complex media
Metal precipitation risks under suboptimal pH or redox conditions
Future models should integrate trace metal mass balances, transporter saturation kinetics, and bioavailability correction factors—especially for Fe and Mo—to predict system yield more accurately under industrial or continuous-use scenarios. For now, metal availability is flagged as a potential hidden bottleneck, capable of undermining even fully expressed enzyme systems.
Both enzymes rely on complex and resource-intensive metalloprotein assembly pathways:
| Enzyme |
Cofactor Requirement |
Biosynthetic Complexity |
| [FeFe]-Hydrogenase |
2–3 Fe atoms per unit; Fe-S clusters |
Dependent on functional HydEFG maturation proteins and iron homeostasis |
| Nitrogenase (NifDK) |
~8 Fe, 7 S, 1 Mo per unit |
Requires full Fe-S cluster biogenesis and molybdenum incorporation via NifEN pathway |
Cofactor Availability and Economic Feasibility Note: Molybdenum (Mo) is an essential cofactor for nitrogenase activity, typically incorporated into the FeMo-cofactor cluster at a rate of ~1 mol Mo per mol of active nitrogenase. For the modelled system—assuming full activation of nitrogenase to produce 10 mol H₂ per cycle—this corresponds to a theoretical requirement of approximately 1 mmol Mo per mole of glucose processed. At current bulk pricing for molybdate salts (e.g., ammonium molybdate), this equates to a cost of less than $0.50 per batch (based on $40 per 100 g, molar mass ≈ 123.9 g/mol). Given its industrial availability, low cost, and widespread use in agriculture, molybdenum does not present a logistical or economic bottleneck for system deployment. However, its bioavailability must be managed carefully to avoid toxicity, and real-world systems may benefit from trace metal recycling strategies to maintain sustainable operation.
4.4.3. NAD(P)H Demand and Redox Balancing
Overexpression of bchP and crtB in R. sphaeroides boosts photosystem formation and light-harvesting efficiency but increases NADPH consumption. Biosynthesis of bacteriochlorophylls and carotenoids requires multiple NADPH molecules per pigment unit, particularly during biofilm establishment phases. This can cause early-stage redox imbalance and may necessitate transhydrogenase activity or metabolic reallocation.
Estimated NADPH diversion during initial pigment biosynthesis may approach 20–30% of the available pool, competing with core metabolic functions if unregulated.
4.4.4. Expression Load and Transcriptional Capacity
Stacking 6–8 genes under high-strength promoters increases the demand for RNA polymerase, ribosomes, and processing enzymes. Even with chromosomal integration, excessive constitutive expression can saturate transcriptional machinery, triggering unintended feedback loops or silencing effects. Promoter crowding, mRNA degradation limits, and translational burden must be considered.
A gene burden summary is provided below:
| Gene |
Resource Burden |
ATP Demand |
Cofactor Required |
Risk Summary |
| hydA↑ |
High |
Moderate |
Fe-S |
Critical but unstable under low Fe |
| crtB↑ |
Medium |
Low |
NADPH |
Affects light-harvesting onset |
| bchP↑ |
High |
High |
NADPH |
Major redox sink; timing-sensitive |
| ackA↑ |
Low |
Net ATP gain |
Acetate flux |
Energy positive |
| hupLΔ |
None |
None |
N/A |
Eliminates H₂ reuptake |
| hydGΔ |
Low |
None |
N/A |
Enables hydA maturation |
4.4.5. Systemic Load Implications
To support these expression demands, the model assumes:
Supplemented growth media with Fe²⁺ (≥20 µM), trace Mo, and buffered NAD⁺/NADP⁺ regeneration capacity
Stage-specific promoter design (e.g., light-inducible for bchP, stress-inducible for hydA) to stagger gene expression
Potential inclusion of ATP-regenerating pathways or cyclic photophosphorylation enhancers
Failure to meet these conditions in practical systems could result in:
Loss of expression fidelity over time
Early plateauing of hydrogen yields due to cofactor exhaustion.
Activation of stress response pathways or unintended mutations in high-burden operons
Author’s Note: While these burdens are quantified to the extent possible within a theoretical framework, their exact thresholds are highly context-dependent and would require dynamic flux balance analysis (dFBA) and proteomic data to model precisely. The intent here is to flag these risks for consideration in future experimental or in silico simulations.
I want to be fully transparent about this part of the model. While I have done my best to design and rationalize the proposed genetic modifications based on existing literature, I do not currently have the expertise—or the computational tools—to model the deeper layers of metabolic burden, cofactor imbalance, or regulatory drift that these changes would realistically trigger.
These things are real and complex, and I do not want to pretend otherwise. Modelling gene expression stability, metabolic flux distributions, or system-wide energy budgets would require advanced simulations like flux balance analysis (FBA), and that is well beyond my current skill set.
So, for now, I am treating these genetic edits as a best-case hypothetical scenario—not because biology is this clean, but because I wanted to explore the ceiling of what such a system might achieve if everything worked optimally.
While this framework establishes a clear theoretical ceiling, it does not include dynamic modelling of intracellular resource allocation, cofactor competition, or redox balancing. Biological systems are governed by non-linear flux networks where enzyme activity, ATP/NAD(P)H levels, and trace metal availability form tightly regulated, feedback-coupled systems. The overexpression of hydrogenase, nitrogenase, and light-harvesting proteins places enormous demand on Fe-S clusters, ATP pools, and NAD(P)H regeneration, all of which interact in ways that static stoichiometric models cannot resolve.
To capture these constraints, future iterations of this model should incorporate flux balance analysis (FBA) or constraint-based modelling (CBM) using genome-scale metabolic reconstructions of C. butyricum and R. sphaeroides. Such tools would allow time-resolved prediction of cofactor depletion, ATP bottlenecks, and gene stack performance under varying substrate, light, and nutrient conditions. Until then, this paper offers an upper-bound performance envelope under the assumption of stable expression, non-limiting cofactors, and uninterrupted energy flux. These assumptions are flagged for future experimental validation or computational refinement.
While cofactor and redox dynamics are acknowledged as critical, they are beyond the current model’s static scope and are proposed for future constraint-based refinement.